Atara jumps amid report on FDA's U-turn on cell therapy
Source: SeekingAlpha
2026-02-25 13:56:52 ET
More on Atara Biotherapeutics
- Atara Biotherapeutics: An Empty Pipeline With Little Gas
- Atara plummets on FDA Complete Response Letter for tabelecleucel
- Seeking Alpha’s Quant Rating on Atara Biotherapeutics
- Historical earnings data for Atara Biotherapeutics
- Financial information for Atara Biotherapeutics
Read the full article on Seeking Alpha
For further details see:
Atara jumps amid report on FDA’s U-turn on cell therapy
Atara Biotherapeutics Inc.
NASDAQ: ATRA
ATRA Trading
-9.43% G/L:
$6.34 Last:
385,698 Volume:
$6.45 Open:
ATRA Latest News
ATRA Stock Data
$36,411,687
4,838,068
18.37%
20
N/A
Biotechnology & Life Sciences
Healthcare
US
Thousand Oaks
